Skip to content

International Bancshares IBOC Loans collectively evaluated for impairment

Loans collectively evaluated for impairment at other companies

JPMorgan Chase logo
JPMorgan ChaseJPM
BOK Financial logo
BOK FinancialBOKF
Valley National Bank logo
Valley National BankVLY

Other financials

Income statement

See full
Revenue$208.5M+5.2%
Net income$102.2M+5.5%
EPS (diluted)$1.64+5.1%

Balance sheet

See full
Cash & equivalents$585.9M-0.6%
Total equity$3.3B+13.6%
Total assets$16.8B+3.4%

Cash flow

See full
Operating cash flow$120.7M-14.0%
CapEx$4.7M-36.5%
Free cash flow$116.0M-12.8%

Valuation

See full
Market cap$4.57B+6.6%

Profitability

See full
Net margin49%-0.5pp
FCF margin53.5%-2.7pp

Returns & leverage

See full
Return on equity13.5%-1.7pp
Debt / equity

Where this comes from

Reported directly by International Bancshares in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableCollectivelyEvaluatedForImpairment.

The official record: International Bancshares’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about International Bancshares's loans collectively evaluated for impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is International Bancshares's loans collectively evaluated for impairment?
International Bancshares (IBOC) reported loans collectively evaluated for impairment of $9.49B in Q1 2026.
How has International Bancshares's loans collectively evaluated for impairment changed year-over-year?
International Bancshares's loans collectively evaluated for impairment increased by 6.4% year-over-year, from $8.92B to $9.49B.
What is the long-term trend for International Bancshares's loans collectively evaluated for impairment?
Over 5 years (2020 to 2025), International Bancshares's loans collectively evaluated for impairment has grown at a 4.4% compound annual growth rate (CAGR), from $7.52B to $9.32B.